Cite
HARVARD Citation
Divakar, S. et al. (2017). Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway. Chemico-biological interactions. pp. 22-34. [Online].